CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Teva Pharmaceuticals USA Inc. v. Synthon Pharmaceuticals, Inc.

1:14-cv-01419

📡 5G SEP • ETSI Declared

Overview

Case Number 1:14-cv-01419
Filing Date 2014-11-18
Status Terminated
Termination Date 2017-01-31
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Teva Pharmaceutical Industries Ltd Operating Company

Represented By

2 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

9 Attorneys Listed

Daryl L. Wiesen

Email: dwiesen@goodwinlaw.com

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John T. Bennett

Law Office of Michael R. Abram

115 South Bedford Street, Georgetown, DE 19947

William G. James

Email: william.james@allenovery.com

David M. Hashmall

Email: dhashmall@goodwinlaw.com

Brian J. Prew

Email: prewb@gtlaw.com

Nicholas K. Mitrokostas

Email: nicholas.mitrokostas@allenovery.com

Elizabeth J. Holland

Email: Elizabeth.Holland@allenovery.com

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Pfizer Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Yeda Research and Development Co Ltd. Operating Company

Represented By

2 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Teva Neuroscience Inc Operating Company

Represented By

2 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Counter Claimant

Synthon s.r.o. Blansko NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Melanie K. Sharp

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6681
Fax: +1 (302) 571-1253

Rodney Square, 1000 North King Street

Synthon B.V. NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Melanie K. Sharp

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6681
Fax: +1 (302) 571-1253

Rodney Square, 1000 North King Street

Synthon Pharmaceuticals Inc. Operating Company

Represented By

6 Attorneys Listed

Sharon L. Davis

Email: sdavis@rfem.com

Seth E. Cockrum

Email: scockrum@rothwellfigg.com

Randy Elizabeth Brenner-Leifer

UNDELIVERABLE EMAIL 10/29/2018

Jennifer P. Nock

Email: jnock@rothwellfigg.com

E. Anthony Figg

Email: efigg@rfem.com

Melanie K. Sharp

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6681
Fax: +1 (302) 571-1253

Rodney Square, 1000 North King Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 4 proceedings
🏛️
USPTO PTAB Trials 4 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (8 found):
PTAB: 4 U.S. Courts: 4
USPTO PTAB Trial 2015-09-25
IPR2015-01980

Amneal Pharmaceuticals LLC v. YEDA RESEARCH & DEVELOPMENT CO. LTD. et al.

U.S. Continuation Sibling (8399413)
Status: Final Written Decision
USPTO PTAB Trial 2015-09-25
IPR2015-01976

Amneal Pharmaceuticals LLC v. Yeda Research & Development Co., Ltd. et al.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2015-02-07
IPR2015-00644

Mylan Pharmaceuticals Inc. et al. v. Yeda Research and Development Co. Ltd. et al.

U.S. Continuation Sibling (8399413)
Status: Final Written Decision
USPTO PTAB Trial 2015-02-06
IPR2015-00643

Mylan Pharmaceuticals Inc. et al. v. Yeda Research and Development Co. Ltd. et al.

Asserted Patent
Status: Final Written Decision
U.S. District Court 2015-02-03
1:15-cv-00124

Teva Pharmaceuticals USA Inc. v. Amneal Pharmaceuticals LLC

Asserted Patent
Status: DED
U.S. District Court 2014-10-06
1:14-cv-01278

Teva Pharmaceuticals USA Inc. v. Mylan Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-09-10
1:14-cv-01172

Teva Pharmaceuticals USA Inc. v. Dr Reddy's Laboratories Ltd

Asserted Patent
Status: DED
U.S. District Court 2014-09-10
1:14-cv-01171

In Re Copaxone 40 MG Consolidated Cases

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Standard Essential Patent (SEP) & FRAND Intelligence

5G SEP • ETSI Declared High-Probability SEP Action

Essential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation

FRAND Encumbered
Essential Standard 4G / 5G LTE Generation: 5G
Standard Setting Org (SSO) ETSI / 3GPP Essential specification under ETSI / 3GPP governance
FRAND Commitment Committed Fair, Reasonable & Non-Discrim.
Known Patent Pools Avanci / Sisvel / Via Licensing Coverage Applicable Declarant: Sharp

Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)

Permanent Injunction Restricted

Asserted by recognized SEP declarant; CJEU Huawei v. ZTE restrictions apply.

✓ Patentee bound by SSO IPR Policy (ETSI Annex 6 / IEEE Patent Policy).
✓ Right to demand global FRAND portfolio determination.
✓ Non-discrimination defense: check licensing terms offered to competing implementers.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8232250
Low frequency glatiramer acetate therapy
Filed: 2011-11-30
Issued: 2012-07-31
Active (5.0 yrs remaining)
Expires: 2031-11-30
US8399413
Low frequency glatiramer acetate therapy
Filed: 2010-08-19
Issued: 2013-03-19
Active (3.8 yrs remaining) +18d PTA
Expires: 2030-09-06

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Procedural / Extension Motion 1 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending
ORAL ORDER re (18 in 1:14-cv-01172-GMS, 16 in 1:14-cv-01419-GMS, 36 in 1:14-cv-01278-GMS, 16 in 1:15-cv-00124-GMS) Status Report filed by Yeda Research and Deve...
Entry #— • 2015-03-09
Procedural / Extension Motion Pending / Under Review
STIPULATION (and proposed order) concerning service of process and to extend time for Synthon to move, answer or otherwise respond to complaint to January 23, 2...
Entry #7 • 2014-12-09 Document →

Docket Entries

(33 total)
Pleading / Complaint

COMPLAINT filed against Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon s.r.o. Blansko - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1628004.) - filed by Yeda Research and Development Co Ltd., Teva Pharmaceuticals USA Inc., Teva Neuroscience Inc, Teva Pharmaceutical Industries Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(etg, ) (Entered: 11/19/2014)

Entry #1 • 2014-11-18
1
Pleading / Complaint

COMPLAINT filed against Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon s.r.o. Blansko - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1628004.) - filed by Yeda Research and Development Co Ltd., Teva Pharmaceuticals USA Inc., Teva Neuroscience Inc, Teva Pharmaceutical Industries Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(etg, ) (Entered: 11/19/2014)

Entry #1 • 2014-11-18
2
Pleading / Complaint

COMPLAINT filed against Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon s.r.o. Blansko - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1628004.) - filed by Yeda Research and Development Co Ltd., Teva Pharmaceuticals USA Inc., Teva Neuroscience Inc, Teva Pharmaceutical Industries Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(etg, ) (Entered: 11/19/2014)

Entry #1 • 2014-11-18
2
Pleading / Complaint

COMPLAINT filed against Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon s.r.o. Blansko - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1628004.) - filed by Yeda Research and Development Co Ltd., Teva Pharmaceuticals USA Inc., Teva Neuroscience Inc, Teva Pharmaceutical Industries Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(etg, ) (Entered: 11/19/2014)

Entry #1 • 2014-11-18
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (etg, ) (Entered: 11/19/2014)

Entry #2 • 2014-11-18
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc